JP2022550608A5 - - Google Patents
Info
- Publication number
- JP2022550608A5 JP2022550608A5 JP2022520780A JP2022520780A JP2022550608A5 JP 2022550608 A5 JP2022550608 A5 JP 2022550608A5 JP 2022520780 A JP2022520780 A JP 2022520780A JP 2022520780 A JP2022520780 A JP 2022520780A JP 2022550608 A5 JP2022550608 A5 JP 2022550608A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- cells
- fusion protein
- disease
- prion disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962909725P | 2019-10-02 | 2019-10-02 | |
| US62/909,725 | 2019-10-02 | ||
| US202063023197P | 2020-05-11 | 2020-05-11 | |
| US63/023,197 | 2020-05-11 | ||
| PCT/US2020/054140 WO2021067864A1 (en) | 2019-10-02 | 2020-10-02 | Zinc finger protein transcription factors for treatment of prion disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022550608A JP2022550608A (ja) | 2022-12-02 |
| JP2022550608A5 true JP2022550608A5 (cg-RX-API-DMAC7.html) | 2023-09-29 |
| JP7824873B2 JP7824873B2 (ja) | 2026-03-05 |
Family
ID=73013822
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022520780A Active JP7824873B2 (ja) | 2019-10-02 | 2020-10-02 | プリオン病の治療のためのジンクフィンガータンパク質転写因子 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20230002459A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4041271A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7824873B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN114728037A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021067864A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2026506083A (ja) | 2023-02-17 | 2026-02-20 | ホワイトヘッド・インスティテュート・フォー・バイオメディカル・リサーチ | エピジェネティック修飾を行うための組成物および方法 |
| WO2025160155A1 (en) | 2024-01-22 | 2025-07-31 | The Broad Institute, Inc. | Epigenetic targeting of prion diseases |
| WO2025194009A1 (en) * | 2024-03-13 | 2025-09-18 | Sangamo Therapeutics, Inc. | Zinc finger proteins for treating prion disease |
| WO2026133078A1 (en) | 2024-12-17 | 2026-06-25 | Fondazione Telethon Ets | Therapeutic strategy for treating copper-mediated pathologies |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5420032A (en) | 1991-12-23 | 1995-05-30 | Universitge Laval | Homing endonuclease which originates from chlamydomonas eugametos and recognizes and cleaves a 15, 17 or 19 degenerate double stranded nucleotide sequence |
| US5792632A (en) | 1992-05-05 | 1998-08-11 | Institut Pasteur | Nucleotide sequence encoding the enzyme I-SceI and the uses thereof |
| US6140466A (en) | 1994-01-18 | 2000-10-31 | The Scripps Research Institute | Zinc finger protein derivatives and methods therefor |
| JP4012243B2 (ja) | 1994-01-18 | 2007-11-21 | ザ スクリップス リサーチ インスティチュート | 亜鉛フィンガータンパク質誘導体およびそのための方法 |
| GB9824544D0 (en) | 1998-11-09 | 1999-01-06 | Medical Res Council | Screening system |
| CA2196419C (en) | 1994-08-20 | 2007-08-21 | Yen Choo | Improvements in or relating to binding proteins for recognition of dna |
| US5789538A (en) | 1995-02-03 | 1998-08-04 | Massachusetts Institute Of Technology | Zinc finger proteins with high affinity new DNA binding specificities |
| US5925523A (en) | 1996-08-23 | 1999-07-20 | President & Fellows Of Harvard College | Intraction trap assay, reagents and uses thereof |
| GB9710809D0 (en) | 1997-05-23 | 1997-07-23 | Medical Res Council | Nucleic acid binding proteins |
| GB9710807D0 (en) | 1997-05-23 | 1997-07-23 | Medical Res Council | Nucleic acid binding proteins |
| DE69942334D1 (de) | 1998-03-02 | 2010-06-17 | Massachusetts Inst Technology | Poly-zinkfinger-proteine mit verbesserten linkern |
| US6140081A (en) | 1998-10-16 | 2000-10-31 | The Scripps Research Institute | Zinc finger binding domains for GNN |
| US6453242B1 (en) | 1999-01-12 | 2002-09-17 | Sangamo Biosciences, Inc. | Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites |
| US6534261B1 (en) | 1999-01-12 | 2003-03-18 | Sangamo Biosciences, Inc. | Regulation of endogenous gene expression in cells using zinc finger proteins |
| US20020061512A1 (en) | 2000-02-18 | 2002-05-23 | Kim Jin-Soo | Zinc finger domains and methods of identifying same |
| BR0109521A (pt) * | 2000-03-24 | 2003-06-10 | Univ Massachusetts Public Inst | Ungulados transgênicos sem prìons |
| AU2001263155A1 (en) | 2000-05-16 | 2001-11-26 | Massachusetts Institute Of Technology | Methods and compositions for interaction trap assays |
| JP2002060786A (ja) | 2000-08-23 | 2002-02-26 | Kao Corp | 硬質表面用殺菌防汚剤 |
| US20050235369A1 (en) * | 2001-03-28 | 2005-10-20 | Yen Choo | Gene regulation II |
| GB0108491D0 (en) | 2001-04-04 | 2001-05-23 | Gendaq Ltd | Engineering zinc fingers |
| AU2002326483A1 (en) * | 2001-07-31 | 2003-02-17 | Simon Eric Aspland | Genetically modified cows having reduced susceptibility to mad cow disease |
| US20040224385A1 (en) | 2001-08-20 | 2004-11-11 | Barbas Carlos F | Zinc finger binding domains for cnn |
| DK3246403T3 (da) | 2005-10-18 | 2020-10-26 | Prec Biosciences | Rationelt designede meganucleaser med ændret sekvens-specificitet og dna-bindende affinitet |
| US20110023147A1 (en) * | 2008-12-04 | 2011-01-27 | Sigma-Aldrich Co. | Genomic editing of prion disorder-related genes in animals |
| EP2566972B1 (en) | 2010-05-03 | 2020-01-15 | Sangamo Therapeutics, Inc. | Compositions for linking zinc finger modules |
| AU2011256838B2 (en) | 2010-05-17 | 2014-10-09 | Sangamo Therapeutics, Inc. | Novel DNA-binding proteins and uses thereof |
| US20120225922A1 (en) * | 2011-03-04 | 2012-09-06 | Qr Pharma | Effective Amounts of (3aR)-1,3a,8-Trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo [2,3-b]indol-5-yl Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration |
| CN102277356B (zh) * | 2011-07-28 | 2012-10-03 | 扬州大学 | 一种山羊朊病毒基因敲除方法 |
| IL264792B2 (en) | 2016-08-24 | 2023-10-01 | Sangamo Therapeutics Inc | Engineered target-specific zinc-finger nucleases |
-
2020
- 2020-10-02 US US17/766,083 patent/US20230002459A1/en not_active Abandoned
- 2020-10-02 JP JP2022520780A patent/JP7824873B2/ja active Active
- 2020-10-02 EP EP20796992.4A patent/EP4041271A1/en active Pending
- 2020-10-02 CN CN202080080713.7A patent/CN114728037A/zh active Pending
- 2020-10-02 WO PCT/US2020/054140 patent/WO2021067864A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Feng et al. | Neutrophil extracellular traps exacerbate secondary injury via promoting neuroinflammation and blood–spinal cord barrier disruption in spinal cord injury | |
| Kamei et al. | Effect of an enhanced nose-to-brain delivery of insulin on mild and progressive memory loss in the senescence-accelerated mouse | |
| Birch | The contribution of astrocytes to Alzheimer's disease | |
| Stowe et al. | CCL2 upregulation triggers hypoxic preconditioning-induced protection from stroke | |
| Corrigan et al. | The neuroprotective domains of the amyloid precursor protein, in traumatic brain injury, are located in the two growth factor domains | |
| Chatziralli et al. | Intravitreal anti-vascular endothelial growth factor agents for the treatment of diabetic retinopathy: a review of the literature | |
| AU2018225493B2 (en) | Early detection of glial cell activation in neurodegenerative or neuroinflammatory diseases | |
| US20150353641A1 (en) | Use of semaphorin-4d binding molecules for treating neurodegenerative disorders | |
| Weber-Adrian et al. | Strategy to enhance transgene expression in proximity of amyloid plaques in a mouse model of Alzheimer's disease | |
| JP7812364B2 (ja) | 好中球性皮膚症の処置のための抗il-36r抗体 | |
| Yin et al. | Optic nerve regeneration: A long view | |
| Majdi et al. | The interplay of microRNAs and post-ischemic glutamate excitotoxicity: an emergent research field in stroke medicine | |
| JP2023511908A5 (cg-RX-API-DMAC7.html) | ||
| Guo et al. | Fasudil reduces β-amyloid levels and neuronal apoptosis in APP/PS1 transgenic mice via inhibition of the Nogo-A/NgR/RhoA signaling axis | |
| Li et al. | Clinical trials of amyloid-based immunotherapy for Alzheimer's disease: end of beginning or beginning of end? | |
| Wu et al. | Administration of rTMS alleviates stroke-induced cognitive deficits by modulating miR-409-3p/CTRP3/AMPK/Sirt1 Axis | |
| JP2022551286A5 (cg-RX-API-DMAC7.html) | ||
| US20240238363A1 (en) | Oral peptide antagonists of multiple chemokine receptors for reversing loss of synapses and dendritic spines | |
| CN114533720A (zh) | Cd36抑制剂在制备抑制脊髓损伤后疤痕形成药物中的应用 | |
| Sussman et al. | Neural tropomodulin: developmental expression and effect of seizure activity | |
| Ghanem et al. | Impact of berberine on some epigenetic, transcription regulation and inflammatory biomarkers in a mice model of epilepsy | |
| Lefebvre-Roque et al. | Toxic effects of intracerebral PrP antibody administration during the course of BSE infection in mice | |
| Péladeau et al. | Targeting IRES-dependent translation as a novel approach for treating Duchenne muscular dystrophy | |
| F. Abisambra et al. | Exploiting the diversity of the heat-shock protein family for primary and secondary tauopathy therapeutics | |
| CN115475247A (zh) | β2-微球蛋白或其抑制剂的制药用途 |